Please login to the form below
Norway
This page shows the latest Norway news and features for those working in and with pharma, biotech and healthcare.
AZ gets US approval for Veltassa rival Lokelma
year and so far include Norway, the UK, Denmark and Germany.
Latest news
-
AZ finally gets EU nod for Veltassa rival Lokelma
It was approved in the EU last July and as of the end of 2017 had been launched in the UK, Norway and Denmark.
-
EUSA receives European green light for kidney cancer treatment Fotivda
The go-ahead is a significant milestone for the relatively young EUSA, and means the once-daily oral can now be launched in the EU plus Norway and Iceland.
-
Shire files dry eye drug lifitegrast in Europe
Rather than submitting the marketing application to the EMA, Shire has filed lifitegrast using the decentralised procedure (DCP) to Denmark, Norway, Sweden, Finland, the UK, Germany, the Netherlands, France, Italy, Portugal,
-
A new decade of disruption: meeting the biosimilar challgenge
for infliximab in Norway, Denmark and Finland and 47% for etanercept in Norway - a move that has prompted a price reduction on the original brand.
-
Value for money healthcare - Macedonia and Estonia lead
The Netherlands and Switzerland came close to meeting all the criteria, ranking just ahead of Norway, Belgium, Iceland, Luxembourg, Germany and Finland. ... Meanwhile, prevention is still a largely unexploited resource for better health and care, but
More from news
Approximately 1 fully matching, plus 124 partially matching documents found.
Latest Intelligence
-
The tipping point
National policy mandates to switch from the originator to biosimilars, as has been the case in Norway, have resulted in rapid and almost complete biosimilar market penetration.
-
Building a bright future
We have many examples where small molecule and biosimilars have improved uptake such as the case of infliximab in Norway, which was supported by the government that sponsored clinical trials showing
-
Pharma deals continue to slide
For example this month, Karo Pharma, Sweden acquired Weifa, Norway for $163m for product and territory complementarity.
-
2016: The year when deal-makers took stock?
product. (According to the journal Biosimilar Development the price of EPO in Norway was sold at an 83% discount from the original price.). ... The rate of uptake of biosimilars in Norway is exceptional, but the upward trend in other countries is still
-
Can biosimilars live up to the hype?
In Norway, biosimilars were welcomed by knowledgeable patient groups who were consulted at every stage and invited to help design the research studies.
More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest appointments
-
Gilead Sciences appoints general manager, Canada
Brysting was most recently general manager of Gilead Nordics, comprising the company's businesses in Sweden, Norway, Denmark, Finland and Iceland.
-
Targovax appoints chief financial officer
Dr Wiklund joins the Oslo, Norway-based immuno-oncology specialist from Aker Biomarine Antarctic, where he served as director of product innovation.
-
Algeta execs join Targovax
Norway's Targovax has added to its senior team with the appointment of two executives from Algeta.
-
Anker Lundemose appointed CEO of Bionor Pharma
The Norway-based biotech, which is focused on peptide-based vaccines for HIV, said Dr Lundemose will take over the role from March 1, when his predecessor Steen Krøyer becomes deputy
-
Matt Regan named AbbVie’s general manager in UK
Matt Regan named AbbVie’ s general manager in UK. Was formerly general manager of Abbott in Norway. ... Regan was formerly general manager for Abbott in Norway and will now oversee the new firm's UK presence as it establishes itself as a separate
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
Featured jobs
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Business Unit Head, Medical Communications, London
-
Excellent package
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
Subscribe to our email news alerts
- Moving annual total (MAT)
- Brexit rebels win vote on European Medicines Agency alignment
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- MaxCyte gets green light for solid tumour cell therapy
- NHS England to Vertex: come clean on Orkambi offer
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Random42 win Creativity International Award for Scientific Animation
- Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
- Aurora partners with PIPHealth and taps into patient panels
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
- OUTiCO growth in multi-channel creates more job openings
PMHub
Streaming Well
Streaming Well is a healthcare focused, award-winning video production company which operates in the US and Europe....
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
